FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_S_3576.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2022-02-03.
What are the main provisions?
Key points include:
- Drugs approved in certain countries (e.g., UK) may be approved faster for sale in the US.
- Confirmation of safety, effectiveness, and manufacturer's ability to produce the drug safely is required.
- A special advisory committee of experts will be established to evaluate foreign drugs.
- Drug approval decisions will be publicly available, along with their rationale.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Braun, Mike [R-IN].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.